CEMI Chembio Diagnostics Inc.

Chembio Diagnostics to Report Second Quarter 2018 Financial Results on August 8, 2018

Chembio Diagnostics to Report Second Quarter 2018 Financial Results on August 8, 2018

MEDFORD, N.Y., July 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, announced today that it will release financial results for the second quarter 2018 after the close of trading on Wednesday, August 8, 2018.  The Company’s management team will host a corresponding conference call beginning at 4:30pm Eastern Time.

Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US.  A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at .  A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 34609 until 4:30pm ET on Wednesday, August 15, 2018.

Contact:

Lynn Pieper Lewis

Gilmartin Group

Investor Relations

(415) 937-5402

EN
25/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chembio Diagnostics Inc.

 PRESS RELEASE

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Biosynex Completes Acquisition of Chembio Diagnostics, Inc. Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced it has completed its acquisition of Chembio Diagnostics, Inc. (“Chembio”), a leading point-of-care diagnostics company focused on infectious diseases. Chembio is now part of Biosynex Group. The complementary nature of the technologi...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: April 25, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: April 20, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York...

Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023 Failure to tender shares could result in the termination of the proposed merger between Chembio and Biosynex MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 Fellow Chembio Stockholders, We strongly urge you to tender your shares of common stock ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch